These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16025585)

  • 41. [Ca 125 in epithelial ovarian cancers of FIGO stage I].
    Nagele F; Kurz C; Vavra N; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():291-2. PubMed ID: 8118320
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
    Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
    Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interdependent prognostic factors in ovarian cancer].
    Pickel H; Lahousen M
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():199. PubMed ID: 8118268
    [No Abstract]   [Full Text] [Related]  

  • 44. P16INK4a overexpression is associated with poor clinical outcome in ovarian carcinoma.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei GL
    J Chemother; 2004 Aug; 16(4):411-3. PubMed ID: 15332720
    [No Abstract]   [Full Text] [Related]  

  • 45. Lysophosphatidic acid: friend or foe of the ovarian surface epithelium.
    Park DJ; Martyn KD; Warn-Cramer BJ
    Hawaii Med J; 2005 Jun; 64(6):164-5, 169. PubMed ID: 16025585
    [No Abstract]   [Full Text] [Related]  

  • 46. Biologic prognostic factors in ovarian cancer: a review.
    Framarino dei Malatesta ML; Veneziano M; Peppicelli M; Lanzi G; Marzetti L
    Eur J Gynaecol Oncol; 1998; 19(2):123-5. PubMed ID: 9611049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors in ovarian cancer.
    Tropé C
    Cancer Treat Res; 1998; 95():287-352. PubMed ID: 9619290
    [No Abstract]   [Full Text] [Related]  

  • 48. Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management.
    Erickson JR; Hasegawa Y; Fang X; Eder A; Mao M; Furui T; Aoki J; Morris A; Mills GB
    Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):63-81. PubMed ID: 11324708
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.